Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

71.4%

-15.2% vs benchmark

Late-Stage Pipeline

15%

2 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed with results

Key Signals

4 with results71% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (8)
P 1 (1)
P 2 (1)
P 3 (2)

Trial Status

Completed5
Unknown4
Terminated2
Recruiting2

Trial Success Rate

71.4%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (13)

Research Network

Activity Timeline